Press Release - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Company dossier
Gland Pharma
NSE:GLAND · ISIN INE068V01023
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Gland Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Gland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gland Pharma LimitedNSE · conference call · pdf
Source filing Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Change in Director(s) - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Gland Pharma LimitedNSE · exchange filing · pdf
Archived filing Gland Pharma Ltd - 543245 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gland Pharma LimitedNSE · conference call · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Shareholders meeting - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gland Pharma LimitedNSE · conference call · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Updates - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gland Pharma LimitedNSE · conference call · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Gland Pharma LimitedNSE · financial results · pdf
Source filing Change in Director(s) - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - Gland Pharma LimitedNSE · exchange filing · zip
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of Board Meeting - 15.06.2026BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Gland Pharma LimitedNSE · exchange filing · pdf
Source filing Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Gland Pharma LimitedNSE · conference call · pdf
Source filing